J&J unit seeks EU approval of TB therapy

Janssen-Cilag International N.V. submitted an MAA to EMA for bedaquiline ( TMC207) to treat multi-drug resistant tuberculosis. Bedaquiline is a diarylquinoline (DARQ) antibiotic that inhibits mycobacterial F1F0-ATP synthase. ...